FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deal with application of pharmaceutically activated relaxin H2 for obtaining medication for treatment of nephrogenic diabetes insipidus in subject, requiring it. Group of inventions also deal with application of pharmaceutically active relaxin H2 for treatment of nephrogenic diabetes insipidus in subject, requiring it.
EFFECT: group of inventions provides relaxation or reduction of excessive production of diluted urine and accompanying complications, associated with nephrogenic diabetes insipidus.
14 cl, 5 ex, 11 dwg, 2 tbl
